BioIVT taps into the advantages of hepatic cells for toxicology evaluations and screening studies, securing exclusive distribution agreement with upcyte.
A team of US scientists have assembled clusters of cells into living ‘microtissues’ as part of a programme aimed initially at reducing the use of animal models in early-stage drug development.
New research has shown that silica nanowires can be used to deliver toxic agents into both human and bovine epithelial cell lines, opening up new options for drug targeting and delivery.
Nikon have launched a new 'hands off' system that combines an
incubator and inverted microscope to allow automated live-cell
culture studies and time-lapse imaging in a controlled environment.
Asterand is to make available novel research materials to be used
in the investigation of rheumatoid arthritis, osteoarthritis,
cancer and other diseases making available a range of cell material
that is currently difficult to obtain.
A new finding has the potential to pave the way for better
treatment options for autoimmune diseases as researchers discover a
signalling molecule can yield a rapid, inexpensive way to make
large numbers of immune cells.
Researchers in the US have developed an exciting new tool that
enables scientists to watch cell chemical activity in real-time.
The tool's development has major implications for speeding up new
drug design.
A research team think that they have discovered a new mechanism
that details the role of sugar in cell communication, which paves
the way for the development of drugs for cancer and rheumatism.
Scientists have found a new way to sneak drugs past the blood-brain
barrier by using stem cell derived brain cells to deliver a
critical growth factor that has already shown clinical promise for
treating Parkinson's disease.
A group of researchers have found that FLT-1 - a molecule
implicated in blood vessel growth - is necessary for the escape of
the leukaemia cells from the bone marrow (BM), suggesting that
blocking of this molecule pharmaceutically...
US researchers have discovered a new immune cell that may play a
key role in inflammatory and autoimmune diseases, which raises the
prospect of finding ways to treat these disorders that include
asthma, arthritis, and multiple sclerosis...
Living Cell Technologies announced a significant reduction in the
size of brain lesions in a Huntington's disease (HD) model after
pre-clinical demonstrated this result using its NeurotrophinCell
(NtCell).
A new device - dubbed an "optoelectronic tweezer," enables
researchers to manipulate large numbers of single cells and
particles using optical images projected onto a glass slide coated
with photoconductive materials. The...
Researchers have used new laboratorial techniques that allowed them
for the first time to derive unlimited numbers of purified
mesenchymal precursor cells from human embryonic stem cells
(HESCs). The cells can be used for regenerative...
A new laboratory technique used by fruit fly geneticists for more
than a decade is now available to scientists studying genes and
diseases in mice. This technique offers a powerful new tool to
study genetics, particularly in disease.
Researchers have identified several proteins on the surface of
cancer cells that contribute to the cells' ability to metastasise.
The finding provides unique drug targets to prevent the cancer
spread and a basis for which new...
Adjuvants - substances that are added to vaccines to intensify the
immune response to an antigen which have been used for over 80
years - are beginning to be understood by researchers who believe
more effective adjuvants can be designed.
Drug discovery instrumentation and software developer Axon
Instruments announced today the release of its Axoporator 800A
single-cell electroporator, the first commercially available
instrument of its kind, writes Wai Lang Chu.
A small German company has developed a new drug delivery technology
that can transport active drugs into the interior of cells by an
intrinsic, active mechanism.
A cell culture vessel designed by Taiwanese company CESCO
Bioengineering can produce the same amount of cells in a single
500ml bottle as would be made in 20 or more conventional roller
bottles, according to the company which is introducing...
A protein that forms part of the cytoskeleton of cells could be a
new target for medicines that prevent the spread of tumour cells
around the body, according to new research published on Nature's
website.
Researchers in the UK have uncovered important clues about how
cells age that could be used to develop treatments that counteract
the ability of cancers to grow and spread.